IntegriChain, a pharmaceutical technology, data, consulting and outsourcing service for data-driven commercialization and backed by Accel-KKR, has named Joshua Halpern, co-founder and current president and chief operating officer, to the role of chief executive officer. Kevin Leininger, current CEO, will transition to the role of executive chairman and remain active in the business strategy.

In his new role, Halpern will be responsible for corporate management and leadership of IntegriChain’s global workforce and strategic planning for the company, focusing on driving business value across the company’s operations. Halpern co-founded IntegriChain in 2006 and brings more than 20 years of experience in pharmaceutical commercialization, data and analytics.

“Josh and I founded IntegriChain 16 years ago and have led the company’s growth side by side,” says Leininger. “He truly understands the challenges that pharma manufacturers face and has played a vital role in delivering a transformative data, technology, service, and consulting platform to the industry. I am proud of the outstanding team that will take IntegriChain forward, I am utterly confident in Josh’s ability to seamlessly lead IntegriChain to the next level, and I consider myself lucky to continue to play an important role on the board going forward.”